Authors: Deres, Friederike | Schwartz, Stephanie | Kappes-Horn, Karin | Kornblum, Cornelia | Reimann, Jens
Article Type:
Research Article
Abstract:
Background: The C22 mouse is a Charcot-Marie-Tooth 1A transgenic model with minimal axonal loss. Objective: To analyse early skeletal muscle changes resulting from this dysmyelinating neuropathy. Methods: Histology of tibialis anterior muscles of C22 mice and wild type litter mate controls for morphometric analysis and (immuno-)histochemistry for known denervation markers and candidate proteins identified by representational difference analysis (RDA) based on mRNA from the same muscles; quantitative PCR and Western blotting for confirmation of RDA findings. Results: At age 10 days, morphometry was not different between groups, while at 21 days, C22 showed significantly
…more small diameter fibres, indicating the onset of atrophy at an age when weakness becomes detectable. Neither (immuno-)histochemistry nor RDA detected extrajunctional expression of acetylcholine receptors by age 10 and 21 days, respectively. RDA identified some mRNA up-regulated in C22 muscles, among them at 10 days, prior to detectable weakness or atrophy, integral membrane protein 2a (Itm2a ), eukaryotic initiation factor 2, subunit 2 (Eif2s2 ) and cytoplasmic phosphatidylinositol transfer protein 1 (Pitpnc1 ). However, qPCR failed to measure significant differences. In contrast, Itm2a and Eif2s2 mRNA were significantly down-regulated comparing 21 versus 10 days of age in both groups, C22 and controls. Western blotting confirmed significant down-regulation of ITM2A protein in C22 only. Conclusion: Denervation-like changes in this model develop slowly with onset of atrophy and weakness at about three weeks of age, before detection of extrajunctional acetylcholine receptors. Altered Itm2a expression seems to begin early as an increase, but becomes distinct as a decrease later.
Show more
Keywords: Skeletal muscle, muscle denervation, charcot-marie-tooth disease, demyelination, gene expression profiling, integral membrane protein 2A, eukaryotic initiation factor 2, beta subunit, phosphatidylinositol transfer protein, cytoplasmic 1
DOI: 10.3233/JND-210681
Citation: Journal of Neuromuscular Diseases,
vol. 8, no. s2, pp. S283-S299, 2021